01:47 PM EDT, 07/11/2024 (MT Newswires) -- Truist Securities raised its price target for Lantheus Holdings ( LNTH ) to $141 from $96 while maintaining its buy rating.

Lantheus ( LNTH ) shares jumped 16% amid heavy trading Thursday after Medicare proposed updated plans related to the reimbursement rate for diagnostic radiopharmaceuticals.

Over 3.62 million shares of Lantheus ( LNTH ) traded intraday versus a daily average of roughly 921,000.

Nut Tree Capital Management and Caspian Capital proposed to acquire Martin Midstream Partners ( MMLP ) for $4 per unit in cash.

Shares of Martin Midstream ( MMLP ) jumped 12% as trading volume advanced to over 338,000 from a daily average of about 79,000.

Truist upgraded Astrana Health ( ASTH ) to buy from hold, pointing to better visibility and underappreciated tailwinds. It also raised its price target to $50 from $44.

Shares of Astrana surged 16% as trading volume climbed to more than 405,000 from a daily average of about 156,000.

Price: 124.31, Change: +18.13, Percent Change: +17.07